Limited Stage Small Cell Lung Cancer Clinical Trials

9 recruiting

Limited Stage Small Cell Lung Cancer Trials at a Glance

8 actively recruiting trials for limited stage small cell lung cancer are listed on ClinicalTrialsFinder across 6 cities in 27 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Graz, Jinan, and Fairfax. Lead sponsors running limited stage small cell lung cancer studies include Cancer Institute and Hospital, Chinese Academy of Medical Sciences, European Organisation for Research and Treatment of Cancer - EORTC, and Amgen.

Browse limited stage small cell lung cancer trials by phase

Treatments under study

About Limited Stage Small Cell Lung Cancer Clinical Trials

Looking for clinical trials for Limited Stage Small Cell Lung Cancer? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Limited Stage Small Cell Lung Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Limited Stage Small Cell Lung Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Limited Stage Small Cell Lung Cancer
SCRI Development Innovations, LLC250 enrolled33 locationsNCT06773910
Recruiting
Phase 3

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Small Cell Lung CancerLimited Stage Small Cell Lung Cancer
Amgen400 enrolled204 locationsNCT06117774
Recruiting
Phase 2

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Limited Stage Small Cell Lung Cancer
Fudan University60 enrolled1 locationNCT06943235
Recruiting
Phase 2

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial

Limited Stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China30 enrolled1 locationNCT06256237
Recruiting
Phase 2

Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients

Limited Stage Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences55 enrolled2 locationsNCT05443646
Recruiting
Not Applicable

PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

Limited Stage Small Cell Lung CancerExtensive-stage Small-cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC600 enrolled41 locationsNCT04790253
Recruiting
Phase 2Phase 3

Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

Limited Stage Small Cell Lung Cancer
Sun Yat-sen University346 enrolled1 locationNCT05623267
Recruiting
Phase 3

Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy

Limited Stage Small Cell Lung Cancer
Shandong Cancer Hospital and Institute534 enrolled2 locationsNCT04829708